Gerresheimer is driving innovation in pharmaceutical glass, primary packaging glass products, technologies and digitised processes.
In the future, highly qualified engineers at the recently opened Gx Glass Innovation and Technology Center will develop innovative solutions for the pharmaceutical sector that meet today’s and future demand of the pharma industry.
During a customer event with more than 100 participants, CEO Dietmar Siemssen opened the new innovation centre in Vineland / New Jersey / US.
We are leading in health and well-being delivery. We are developing first-class glass solutions to meet highest quality requirements. In our new innovation centre, we will bundle our glass expertise and all our experts to develop new products and technologies, together with our customers in one place. Among those enhanced value propositions for our customers are Gx Elite Glass, ready-to-fill vials, strengthened glass and much more to come,” said Dietmar Siemssen, CEO of Gerresheimer AG, in his opening speech at the new Gx Glass Innovation and Technology Center. Gerresheimer has made significant investments in its production sites in the Americas over the past few years.
In the Gx Glass Innovation and Technology Center, the company will intensify glass innovations as well as optimize all its processes to enable the Gerresheimer plants worldwide to make pharmaceutical glass of the highest quality. The team will work on new products, further digitization, process capabilities, camera inspection systems and much more.
Pooled development capacity
There are clear benefits to pooling development capacity at a single site: 25 experts and engineers specialised in glass technology will work together on innovation in a setting that is conducive to collaboration thanks to an open-plan office, project and meeting rooms, allowing interactive co-working with customers onsite.
The innovation centre is the first of its kind for Gerresheimer Primary Packaging Glass and was recently built next to the tubular glass converting plant in Vineland. Thereby the innovation centre can develop new products and processes very close to a production site, involving the operational expertise of the engineers at that plant.
Gerresheimer at CPhI Worldwide
As a leading specialist in the packaging and administration of drugs, Gerresheimer has participated in CPhI Worldwide for many years. CPhI stands for Convention of Pharmaceutical Ingredients and has been the most important trade fair for the development and marketing of pharmaceutical ingredients for 30 years. This year the CPhI takes place in Frankfurt.
Gerresheimer will be at booth 111B10 in Hall 11.2 in the Innopack area.
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers.
With plants in Europe, North America, South America and Asia, Gerresheimer generates revenues of around EUR 1.4 bn. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.